The prognostic value of neutrophile/lymphocyte ratio and serum chemerin to predict maternal-fetal complications in pregnant systemic lupus erythematosus patients.

BACKGROUND: Pregnancy in SLE continues to be a challenge. The neutrophil-to-lymphocyte ratio (NLR) and chemerin are predictors of preeclampsia in the general population; however, their role as predictors of maternal-fetal complications in pregnant SLE patients has not been analyzed. OBJECTIVE: To investigate the prognostic value of NLR and serum chemerin, to predict maternal-fetal complications in pregnant SLE patients, and compare both biomarkers among three study groups. METHODS: Design: Analytical cross-sectional study of cases and controls with the following study groups: systemic lupus erythematosus (SLE), preeclampsia, and healthy. NLR and chemerin serum were determined between 20 and 25 weeks of gestation. Patients were evaluated every 4-6 weeks until pregnancy resolution. Maternal and fetal outcomes were registered. We employed Receiver Operating Characteristic (ROC) curves to validate prognostic values. RESULTS: Seventy pregnant patients were included: 20 with SLE, 20 with preeclampsia, and 30 healthy pregnant women; NLR values were 4 (2.3-5.6) in SLE, 6 (4.6-9.2) in preeclampsia, and 2.8 (2.1-2.9) in the group of healthy women (p = .0001). Chemerin levels were: 26 (15.3-56.2) in SLE, 96 (37.3-146.2) in preeclampsia, and 24.6 ng/mL (15.3-47.4) in the healthy group (p = .007) Maternal complications were observed in 11 (55%), 20 (100%), and 8 (26%) per group, respectively. Thrombocytopenia was the most frequent complication in all pregnant women, followed by hypertensive disorders. Fetal complications were registered in 12 (60%), 16 (80%), and 2 (6.7%), respectively. Congenital malformations and prematurity were the most frequent fetal complications. NLR had good diagnostic accuracy in predicting maternal-fetal complications (AUROC 0.715) p = .015, CI 95% 0.56-0.86, cut-off point level: 2.9, sensitivity 61%, specificity 78%, positive predictive value (PPV) 65%, negative predictive value (NPV) 75%. Regarding chemerin, a cut-off point level >43 ng/mL had a sensitivity of 75%, specificity of 72% AUROC 0.75, p = .001, CI 95% 0.61-0.89, PPV 51.7% NPV 87.8%, meaning that 51.7% of patients with chemerin levels >43 ng/mL have or will have preeclampsia. CONCLUSION: The NLR may help predict maternal-fetal complications in SLE pregnancy, constituting a marker of subclinical inflammation. Chemerin levels may be associated with preeclampsia. These biomarkers could improve the care of SLE patients with timely intervention of potential complications during pregnancy.

Prevalence, causes, and clinical course of patients with surgical reintervention due to complications during cesarean section.

OBJECTIVE: The objective of the study is to identify the prevalence, causes, and clinical evolution of patients with surgical reintervention due to complications during cesarean section. MATERIALS AND METHODS: The file of the Toco-Surgical Unit of the Gynecological Obstetrics Hospital No. 3 of the National Medical Center "La Raza" Mexican Institute of Social Security was reviewed to know the total number of patients undergoing cesarean section from January to December 2019 and cases with reintervention due to complications during cesarean section were selected. Their general data, the cause of reintervention, stay in the intensive care unit (ICU), hospital stay, and mortality were studied. The data were analyzed with descriptive statistics using the statistical program SPSS version 20. RESULTS: It was found that 3371 patients underwent cesarean section, of which 1.60% (54 cases) underwent reoperation for the following reasons: Unpacking 27.79%, obstetric hemorrhage 20.37%, bleeding due to uterine atony 20.37%, hysterotomy commissure hematoma 18.52%, uterine infiltration 3.70%, vascular injury 3.70%, bladder injury 3.70%, and colonic injury 1.85%. The ICU stay was 3.79 ± 2.03 days, hospital stay was 13.67 ± 11.16 days, and mortality was 1.85%. CONCLUSION: The prevalence of reintervention was reduced, bleeding was the main cause, and the clinical evolution was satisfactory with low mortality.

OBJETIVO: Identificar la prevalencia, causas y evolución clínica de las pacientes con reintervención quirúrgica por complicaciones durante la cesárea. MATERIAL Y MÉTODOS: Se revisó el archivo de la Unidad de Toco-Quirúrgica del Hospital Ginecobstetricia No. 3 del Centro Médico Nacional "La Raza" Instituto Mexicano del Seguro Social para conocer el total de pacientes sometidas a cesárea desde enero hasta diciembre de 2019 y se seleccionaron los casos con reintervención por complicaciones durante la cesárea. Se estudiaron sus datos generales, la causa de reintervención, estancia en la Unidad de Cuidados Intensivos (UCI), estancia en hospital y la mortalidad. Los datos se analizaron con estadística descriptiva utilizando el programa estadístico SPSS versión 20. RESULTADOS: Se encontró que 3371 pacientes fueron sometidas a cesárea de las cuales 1.60% (54 casos) se reintervinieron por las siguientes causas: desempaquetamiento 27.79%, hemorragia obstétrica 20.37%, sangrado por atonía uterina 20.37%, hematoma de la comisura de histerotomía 18.52%, infiltración uterina 3.70%, lesión vascular 3.70%, lesión vesical 3.70% y lesión colónica 1.85%. La estancia en UCI fue 3.79 ± 2.03 días, estancia en hospital 13.67 ± 11.16 días y mortalidad 1.85%. CONCLUSIÓN: La prevalencia de reintervención fue reducida, el sangrado fue la principal causa y la evolución clínica resultó satisfactoria con baja mortalidad.

Plasma colloid osmotic pressure in preeclampsia. Review of the Mexican literature 1997-2018.

En México, la presión coloidosmótica del plasma ha sido un tema clave del estudio de la mujer embarazada por más de dos décadas. Las investigaciones clínicas han permitido conocer sus valores en población abierta, mujeres con embarazo normal, puerperio fisiológico, preeclampsia severa, síndrome HELLP y eclampsia. También se ha reportado la relación de la presión coloidosmótica del plasma con la presión sanguínea (índice de Briones), síndrome de fuga capilar y la acumulación de líquido en cavidades serosas (derrame pleural, ascitis). Revisamos la base de datos PubMed, The Cochrane Library, OVID, Science Direct, Google Scholar, Artemisa, LILACS e IMBIOMED de 1997 a 2018 con las siguientes palabras clave: albúmina sérica, presión coloidosmótica del plasma, síndrome de fuga capilar, índice de Briones, derrame pleural, ascitis, preeclampsia severa, síndrome HELLP, eclampsia y cuidados críticos en obstetricia. Los criterios de inclusión fueron revisiones sistemáticas, meta-análisis, ensayos clínicos controlados y artículos con metodología de medicina basada en evidencia con recomendaciones sólidas. Incluimos 12 artículos mexicanos. Los objetivos de la presente investigación fueron: revisar la literatura médica de la presión coloidosmótica del plasma en preeclampsia reportada de 1997 a 2018, describir el tratamiento con albúmina humana y las perspectivas de la investigación en los siguientes años.In Mexico, plasma colloid osmotic pressure has been a key issue in the study of pregnant women for more than two decades. Clinical investigations have allowed to know their values in the open population, as well as in women with normal pregnancy, physiological puerperium, severe preeclampsia, HELLP syndrome, and eclampsia. The relationship of plasma colloid osmotic pressure with mean arterial pressure (Briones index), capillary leak syndrome and the accumulation of fluid in serous cavities (pleural effusion, and ascites) have also been reported. We reviewed the database of PubMed, The Cochrane Library, OVID, Science Direct, Google Scholar, Artemisa, LILACS, and IMBIOMED from 1997 to 2018 with the following keywords: serum albumin, plasma colloid osmotic pressure, capillary leak syndrome, Briones index, pleural effusion, ascites, severe preeclampsia, HELLP syndrome, eclampsia, and obstetrics critical care. Inclusion criteria were systematic reviews, meta-analysis, clinical controlled trials, and articles with evidence-based medicine methodology with strong recommendations. We included 12 Mexican articles. The objectives of the present investigation were to review the medical literature on plasma colloid osmotic pressure in preeclampsia reported from 1997 to 2018, describe the treatment with human albumin and the perspectives of the research in the following years.

Ruptured hepatic hematoma managed with a Sengstaken-Blakemore probe in severe preeclampsia with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome.

We report the case of a 34-year-old woman with a 32-week pregnancy complicated by recurrent severe preeclampsia, HELLP Class I syndrome, and an intact hepatic hematoma of the right lobe detected by ultrasound. During the cesarean section, the rupture of the hematoma occurred and a gastroesophageal probe of the Sengstaken-Blakemore type was placed to occlude the bleeding cavity and the exit tunnel. The balloons were deflated gradually and the probe was removed on the 10th day without complications. The Sengstaken-Blakemore probe can be an effective remedy to control liver bleeding in selected cases.

Reportamos el caso de una mujer de 34 años con embarazo de 32 semanas complicado con preeclampsia grave recurrente, síndrome HELLP de clase I y hematoma hepático intacto del lóbulo derecho detectado por ultrasonido. Durante la operación cesárea se rompió el hematoma, por lo que se colocó una sonda gastroesofágica de tipo Sengstaken­Blakemore para ocluir la cavidad sangrante y el túnel de salida. Los balones fueron desinflados paulatinamente y la sonda se retiró el décimo día sin complicaciones. La sonda de Sengstaken­Blakemore puede ser un recurso efectivo para controlar el sangrado hepático en casos seleccionados.

Perinatal complications in women with kidney transplant.

BACKGROUND: Pregnancy in patients with kidney grafts is considered high-risk. OBJECTIVES: Determine perinatal complications in women with kidney transplants treated by our hospital and compare them with complications reported in national and international literature. MATERIAL AND METHOD: We studied perinatal complications in 18 patients with renal transplantation who delivered 19 newborns and were treated between 1 January 2009 and 31 December 2010. Results were compared with previous reports. RESULTS: Maternal age: 28.27 ± 4.70 years old, parity: 2, interval from transplant to conception: 7.52 ± 6.20 years, first prenatal visit 14.35 ± 6.74 weeks, prenatal care: 18.88 ± 9.18 weeks, 6 prenatal visits, gestational age at birth: 33.11 ± 8.72 weeks. Maternal complications: cesarean section: 88.88%, blood transfusion: 38.88%, anaemia: 33.33%, premature rupture of membranes: 22.22%, preterm delivery: 22.22%, urinary tract infection: 16.66%, preeclampsia: 11.11%, uncontrolled hypertension: 11.11%, miscarriage: 11.11%, uterine antony: 5.55%, gestational diabetes: 0%, and mortality: 0%. Foetal complications: premature birth: 52.63%, mortality: 21.05%, intensive care: 21.05%, and low birth weight due to growth restriction: 10.52%. Transplantation complications: filtration impairment without need for dialysis: 5.55%, graft rejection: 0%, and graft loss: 0%. CONCLUSIONS: The frequency of perinatal complications was high. Pregnancy had no adverse effect on renal function and patient survival. Stable renal grafts in women of childbearing age is not necessarily a contraindication for pregnancy.